• No results found

Jeffrey D. Baxter, MD Curriculum Vitae

N/A
N/A
Protected

Academic year: 2021

Share "Jeffrey D. Baxter, MD Curriculum Vitae"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

(1)

Jeffrey D. Baxter, MD

Curriculum Vitae

Education

• MD 1996 Washington University School of Medicine, St. Louis, MO • BA 1991 University of Rochester, Rochester, NY

Residency Training

• Family Medicine: University of Massachusetts Medical Center, 7/1996-6/1999 o Chief Resident, 7/1998-6/1999

Fellowship Training

• Addiction Medicine: Boston University Medical Center, 7/02-6/03

o One year training program focusing on medical detoxification, opiate substitution therapies, inpatient and outpatient substance abuse treatment programs, psycho-therapy techniques and evaluation and management of patients with co-occurring disorders • Faculty Development: Community Faculty Development Center, University of Massachusetts

Medical School, 9/2001-7/2002

o Part-time academic fellowship focused on the development of teaching, research and leadership skills

Board Certification

• American Board of Family Practice, 1999, re-certification 2006 • American Board of Addiction Medicine, 2009

Certificates of Added Qualification

• American Society of Addiction Medicine (ASAM) certified by examination, 12/04/04 Faculty Appointment

• Assistant Professor: University of Massachusetts Department of Family Medicine, 1999-present Medical Licensure and Hospital Affiliations

• Active Massachusetts medical license, full and unrestricted • Admitting privileges at UMass-Memorial Medical Center Clinical Experience

• Medical Director: Spectrum Health Systems, 12/2009-present

o Medical director for multi-site outpatient methadone maintenance programs

• Medical Director: Community Health Link Adult and Adolescent Detoxification Units, Worcester, MA, 9/1999- present.

o Program design, implementation and ongoing support for detoxification units • Faculty Physician: Family Health Center of Worcester, 9/1999- present

• Medical Provider: Spectrum Health Systems, 5/2003-5/2005; 1/2009-12/2009 o Medical provider for methadone maintenance treatment program o On-site medical consultation for patients in addiction treatment programs • Addictions Consultant: Massachusetts Department of Corrections 6/2001-present

o Detoxification and opiate maintenance for pregnant inmates o Ongoing revision of detoxification protocols for state prison system

• Medical Director: HABIT-OPCO methadone maintenance program, Springfield, MA, 5/2007 to 2/2009.

(2)

Research Position

• Co-Investigator: Center for Health Care Policy and Research, University of Massachusetts Medical School, 9/2005-present

o Part of a team of health services researchers looking at the impact of mental health and substance use disorders on costs, utilization and other chronic illnesses.

Publications

• Baxter JD, Clark RE, Samnaliev M, Leung GY, Hashemi L. Factors Associated with Medicaid Patients’ Access to Buprenorphine Treatment. J Subst Abuse Treat. 2011 Jul;41(1):88-96. • Clark RE, Samnaliev M, Baxter JD, Leung GY Should Medicaid programs ration opioid

addiction treatment with buprenorphine? Health Affairs, in press.

• Weir S, Posner HE, Zhang J, Willis G, Baxter JD, Clark RE. Predictors of Prenatal and

Postpartum Care Adequacy in a Medicaid Managed Care Population. Women’s Health Issues, in press.

• Baxter, Jeffrey D. Clinical Management I:Buprenorphine Treatment in Office-Based Settings. In Handbook of Office-Based Buprenorphine Treatment of Opioid Dependence, Renner JA and Levounis P, Eds. American Psychiatric Publishing, 2011.

• Clark RE. Weir S. Ouellette RA. Zhang J. Baxter JD; Beyond health plans: behavioral health disorders and quality of diabetes and asthma care for Medicaid beneficiaries; Medical Care. 47(5):545-52, 2009 May.

• Samnaliev, M., Baxter, J.D., Clark, R.E. Comparative Evaluation of Two Asthma Care Quality Measures Among Medicaid Beneficiaries. Chest, 135(5), 1193-1196, 2009.

• Clark, R.E. and Baxter, J.D.; Buprenorphine Treatment for Opioid Dependence. Buprenorphine Knowledge Asset, Web site created by the Robert Wood Johnson Foundation’s Substance Abuse Policy Research Program; March 2009.

http://www.saprp.org/KnowledgeAssets/pdf/Buprenorphine_PolicyBriefReport.pdf

• Baxter J, Samnaliev M, Clark R. The Quality of Asthma Care Among Adults with Substance-Related Disorders and Adults with Mental Illness, Psychiatric Services 60:43-49,2009. • Baxter J, Samnaliev M, Clark R. Patterns of Health Care Utilization for Asthma Treatment in

Adults with Substance Use Disorders, Journal of Addiction Medicine, Volume 2, Number 2, June 2008.

• Renner J, Baxter J, and Ciraulo D. Depression and Substance Abuse in The Treatment of Depression, R Schrader Ed., 2004

Grant Funded Projects

• Co-investigator, 1R01DA029741-01, Robin Clark PhD. (PI) 9/15/10 – 8/31/13

o Cost, Benefit and Regulation of Buprenorphine Treatment for Medicaid Beneficiaries. • Expert Advisory Panel Member and Curriculum Resource Author. NIDA Prime Contract

No.:N01DA-09-1142 /HHSN271200900021C. Title: Primary Care Physician Outreach. WOA Title: Centers of Excellence for Physician Information. Client Agency: NIH. 4/2/10 - 9/17/11 • Expert Advisory Panel Member and Curriculum Resource Author: NIDA Prime Contract No.:

NO2-DA-4-0252/HHSN2682004740252. Title: Primary Care Physician Outreach. WOA Title: Centers of Excellence for Physician Information. Client Agency: NIH. JBS Project No: 00270 9/1/07-- 9/29/09

a. Curriculum Resource Author: Preventing and Detecting the Misuse of Prescription Opioids in Patients with Chronic Non-Malignant Pain. Available at:

http://drugabuse.gov/coe/cr-overview.htm

• Co-Investigator: Robert Wood Johnson Foundation (PI: R. Clark). The impact of buprenorphine on Medicaid expenditures. $99,449. 8/1/08 – 7/31/09

• PI: Creation of a Multi-Site, Ambulatory Treatment and Research Network to Facilitate and Evaluate Buprenorphine Maintenance Treatment for Latinos and other Underserved Populations; Commonwealth Medicine,6/2006-6/2008 $44,000

• PI: Implementation of a Standardized Alcohol Withdrawal to Improve Clinical Outcomes in Correctional Settings, Commonwealth Medicine, 6/2004-6/2006 $21,000

(3)

Regional/National Programs

• Physician Mentor: Methadone Physician Clinical Support System (PCSS-M), 6/2009-present o SAMSHA funded national program modeled after similar program for buprenorphine

treatment. Goal to provide mentorship to providers providing pain treatment with methadone and other opioid medications.

• Physician Mentor: Buprenorphine Physician Clinical Support System (PCSS), 6/2005-present o SAMSHA funded program; one of 70 physicians nation-wide chosen to mentor other

physicians establishing buprenorphine treatment programs

• Panelist: Surgeon General’s Expert Panel on Prescription Drug Abuse in Youth. Washington D.C. March, 2011.

• Faculty: Safe and Effective Opioid Prescribing for Chronic Pain, 2010-present.

o Recurring continuing education program for medical providers sponsored by the Massachusetts Board of Registration in Medicine and the Massachusetts Department of Public Health.

• Faculty: American Academy of Addiction Psychiatry Buprenorphine Training Courses, 5/2005-2009.

o Required course to prescribe buprenorphine for treatment of opiate dependence • Faculty: Excellence in Medical Education Program, Massachusetts Consortium of Medical

Schools: NIDA Center of Excellence (COE) in Substance Abuse Education, 2007-present. o Grant funded program focusing on developing curriculum about the detection and

prevention of the abuse of prescription opioids.

• Consultant: Massachusetts Behavioral Health Partnership (MBHP) Office-Based Treatment of Opioid Dependence with Buprenorphine, Quality Improvement Program, 2008

o Assist in development and dissemination of treatment guidelines

o Provide series of educational programs for providers in Massachusetts, June 2008 • Program Chair: ADHD and Co-occurring Substance Use Disorders

o American Society of Addiction Medicine sponsored conference, March 2007 Invited Presentations

Using Drugs to Treat Drug Addiction: Why it makes sense. Massachusetts Association of Drug Court Professionals, May 17, 2011.

Monitoring Patients on Chronic Opioid Therapy, Massachusetts Academy of Family Physicians Annual Conference, April 2011.

Integrating Medication-Assisted Treatment into Drug Court Proceedings. SAMHSA/BJA joint conference for Drug Court Enhanced Program grantees. Washington DC, January 25, 2011 • Minimizing Risk of Opioid Misuse in Primary Care Settings: A part of the CSAT/SAMHSA

supported project, Optimal Management of Pain in the UCLA Healthcare System: Balancing Safety and Efficacy

o Lecture and panel discussion, Los Angeles Veteran’s Administration Semi-annual Medical Staff Meeting, September 24, 2010

o Workshop, UCLA Internal Medicine Residency Program, September 22, 2010 o Grand Rounds, UCLA/Santa Monica Hospital Department of Family Medicine,

September 22, 2010

Exit Strategies: Transitioning Patients from Opioids

o Workshop. Conference: Effective Management of Chronic Pain and Addiction in Primary Care. Sponsor: Tufts University. May 8, 2010

Peri-partum Pain Management for Women on Methadone and Buprenorphine Treatment o Grand rounds: Departments of OB/GYN and Anesthesia, University of Massachusetts

Medical School, January 2010.

Minimizing Risk in the Prescription of Opioid Pain Medications

o Lecture Presentation, Massachusetts League of Community Health Centers Educational Forum, June 2009

(4)

Medication-Assisted Treatment for Addiction: What Role for the Behavioral Health Provider? o Lecture Presentation, Spectrum Health Systems Annual Behavioral Health Seminar, June

2009

Making the Sum Greater than its Parts: Building an Integrated Team Among Physicians and Behavioral Health Providers for Addressing Substance Abuse in Primary Care

o Plenary: MaineHealth Mental Health Integration Project Annual Conference, June 2008 • The Interface Between Pain and Addiction

o Workshop: MaineHealth Mental Health Integration Project Annual Conference, June 2008

Navigating the Substance Abuse Treatment System

o Biennial Seminar, Heller Graduate School of Public Policy, Brandeis University, November 2005, Oct 2007, October 2009

Treatment for Alcohol and Drug Withdrawal in Correctional Settings

o Workshop, Hamden County Correctional Institute, Ludlow, MA, June 2007 • Perspectives on Addiction and Anxiety

o Annual Meeting, North County Council on Co-occurring Disorders, Fitchburg, MA, May 2007

Detoxification Treatment in the Criminal Justice System

o Presentation, Massachusetts Psychiatric Society Interest Group on Addictions, Boston, MA, January 2007

The Interface between Addiction and Corrections

o Ruth Fox Course for Physicians, American Society of Addiction Medicine. San Diego, CA, May 2006.Pharmacotherapy for Addiction in Primary Care Massachusetts Academy of Family Physicians Annual Spring Educational Conference, May 2006

Buprenorphine Treatment in Primary Care: Making it Work in a Community Health Center Setting

o Presentation to Massachusetts League of Community Health Centers Annual Meeting, May 2006

Management of the Addicted Hospital Inpatient

o Grand Rounds, Tobey Hospital, Wareham, MA, June 2007 o Grand Rounds, Lowell General Hospital, Lowell, MA, June 2006 o Grand Rounds, Jordan Hospital, Plymouth, MA, June 2006

o Grand Rounds, Department of Family Medicine, Health Alliance Hospital, Leominster, MA, December 2004

Tools of the Trade: Treating Substance Abuse in Primary Care.

o Fitchburg Family Medicine Residency Workshop, November 2004 • Opiate Abuse and Maintenance Therapies

o Grand Rounds, Boston University Department of Family Medicine, May 2003 • Effective Communication with Substance Abusers

o Workshop for Boston University Family Practice Residents, July 2003 Academic Conference Presentations

Knowing When to Say When: Exit Strategies from Opioid Therapy

o Workshop, Society of Teachers of Family Medicine Annual Conference, New Orleans, LA, April 2011

Minimizing Risk in the Prescription of Opioids for Chronic Pain

o Faculty development workshop: Association for Medical Education and Research in Substance Abuse (AMERSA), November 2009

o Society of Teachers of Family Medicine Predoctoral education conference, Jacksonville, FL, January 2010.

o American Society of Addiction Medicine annual Medical-scientific conference, San Francisco, CA, April 16, 2010.

The Effect of Co-Occurring Mental Illness on Buprenorphine Treatment: Using Administrative Data to Evaluate Quality in Buprenorphine Treatment

(5)

o Paper Presentation: The Quality of Behavioral Healthcare: A Drive for Change Through Research, Clearwater, FL, April 2010

Characteristics of Patients Receiving Buprenorphine and Methadone Maintenance Treatment in Massachusetts Medicaid: A Comparison of Medical and Psychiatric Co-Morbidities.

o Paper Presentation: Association for Medical Education and Research in Substance Abuse (AMERSA), Bethesda, MD, November 2009

Buprenorphine Treatment in an Inner-city Community Health Center: Patient Characteristics and Correlates of Treatment Retention

o Poster, Association for Medical Education and Research in Substance Abuse (AMERSA), Bethesda, MD, November 2009.

Characteristics of Patients in Buprenorphine Treatment in an Inner-city Community Health Center: Are We Reaching our Core Community?

o Presentation, Association for Medical Education and Research in Substance Abuse annual conference, Washington, DC, November, 2008.

The Quality of Asthma Care in Patients with Substance Use Disorders

o Presentation, Addiction Health Services Research meeting, Boston, MA, October, 2008 • Achieving Quality Asthma Care in Patients with Mental Illness and Addiction

o Presentation, UMASS Commonwealth Medicine Annual Academic Conference, Worcester, MA, 10/25/07

Tackling Tobacco in Addiction Treatment Programs: Are You Up To the Challenge? o Workshop, Cape Cod Symposium on Addictive Disorders, Hyannis, MA, 9/8/2007 • Patterns of Health Care Utilization for Asthma Treatment in Patients with Substance Use

Disorders

o Paper Presentation, American Society of Addiction Medicine Annual Medical-Scientific Conference, Miami, FL, 4/27/2007

Medication Assisted Treatment for Opiate Dependence in Correctional Settings

o Workshop, American Society of Addiction Medicine Annual Medical-Scientific Conference, Miami, FL, 4/27/2007

Medication Assisted Treatment for Opiate Dependence in Correctional Settings

o Lecture presentation, UMASS Academic Correctional Health Conference, Boston, MA, 2007, 2008

Addiction Treatment in Correctional Settings: Detoxification and Methadone Maintenance Issues o Workshop, American Society of Addiction Medicine Annual Scientific Conference, San

Diego, CA. May, 2006

Treating Addiction in Family Medicine Settings

o Poster, American Society of Addiction Medicine Annual Scientific Conference, San Diego, CA. May, 2006

Implementation of a Standardized Protocol for Treating Alcohol Withdrawal in the Massachusetts State Department of Correction

o Presentation, UMASS Commonwealth Medicine Annual Academic Conference, April 2006

UMASS Medical School Presentations and Curricula

• Course Director: Managing Chronic Pain in Primary Care Settings

o Annual course for the third year medical school class, 2008-present

Enhanced Interdisciplinary Primary Care Teams for Managing Patients with Substance Abuse o Semi-annual Seminar: UMASS Certificate Program in Primary Care Psychology,

2007-present

Strategies for Success: Approaches to Addiction and Pain for the Nurse Practitioner. o Annual seminar: UMASS graduate school of nursing, 2004-present.

• Family Medicine Grand Rounds

o Exit Strategies from Opioid Therapy, January 25, 2011

o Minimizing Risk in Prescribing Opioids for Chronic Pain, April 2009

o Substance Abuse in Pregnancy: Practical Topics for Family Medicine, June 2004 o Buprenorphine for Office-based Opiate Maintenance Therapy, September 2003

(6)

o From DT’s to Cocaine Cravings: Care of the Hospitalized Substance Abuse, November 2002

• Programs for Other UMASS Departments o Prescription Drug Abuse

Seminar, UMASS Addiction psychiatry fellowship 2011 o Medical complications of IV Drug Abuse

Seminar, UMASS Addiction psychiatry fellowship 2011 o Minimizing Opioid Misuse in the Treatment of Chronic Pain

Grand Rounds, UMASS Rheumatology Department, January 2011 o Outpatient Treatment for Opiate Dependence with Buprenorphine

UMASS Toxicology Fellowship Program, June 2007

o The Dope on Dope: A Guide to Opiate Abuse for the Infectious Disease Provider Department of Infectious Disease, November 2003

o Outpatient Pharmacotherapy for Substance Abuse Lecture for Psychiatry residents February 2005

o Managing Intoxication and Detoxification in Hospitalized Patients

Lecture for Psychiatry residents at the University of Massachusetts, January 2003; January 2004

UMASS Family Medicine Residency Curricula Pain and Addiction

o Annual workshop for second year residents, 2005-present

Communicating with Patients about Substance Abuse in Primary Care Settings o Annual workshop for second year residents, 2004-present

Introduction to Addiction and Addiction Treatment o Annual workshop for first-year residents

Minimizing the Misuse of Prescription Drugs: Strategies for safer prescribing o Annual workshop, first year residents 2010 to present

Treating the Hospitalized Opiate Abuser—Managing Withdrawal and Pain o Repeating lecture: UMASS Family Medicine Residency Inpatient Service • UMASS Family Medicine residency core curriculum presentations:

o Detecting and Preventing the Abuse of Prescription Medications, April 2008 o Buprenorphine Treatment for Opiate Dependence in Primary Care, May 2006 o Management of Alcohol Problems in Outpatients, March 2006

o Sedative-Hypnotics and Stimulants: Intoxication and Withdrawal, May 2005 o Treating Alcohol Withdrawal in the Hospitalized Patient, February 2005, July 2007 o Treating Substance Abuse in Primary Care, August 2004

Honors

• Young Educator Award, 2008. Association for Medical Education and Research in Substance Abuse (AMERSA)

Medical Society Work

• Massachusetts Society of Addiction Medicine (MSAM) o Board: 6/2005-2008

o Treasurer: 3/2006-2008

o CME committee co-chair: 6/2005-6/2007 • American Society of Addiction Medicine (ASAM)

(7)

International Experience

• Family Medicine Post-Graduate Training Initiative: Ahmedabad, India February 2001 • International Medical Elective: Costa Rica, March 1999

• Amigos de las Americas

o Field Supervisor, 1993. Michoacan, Mexico o Project Volunteer, 1992. Oaxaca, Mexico Language Skills: Spanish, Portuguese

References

Related documents

[r]

The duration of the frame transmission, arrival rate of frames, inter-frame delay, and other observable traffic characteristics differ among different implementations of the

The system must detect and log any authorized clients associating to an unauthorized access point or communicating in ad-hoc mode with an unauthorized client.. Detect and log

Interview with G2’s Senior Analyst, at MONUSCO Headquarters, Goma, September 1, 2015. 34 Interview with Force Commander, at MONUSCO Headquarters, Goma, September 5, 2015. 35

In summary, our study shows that rats fed a high fat diet for 2 months and subsequently supplemented with GbE for 2 weeks showed significant reduction in several biomarkers of

Advertising Expense Event Expense Loan RepaymenURelmbursement Solicitation/Fundraising Expense Accounting/Banking Fees Office Overhead/Rental Expense Transportation

Although virus shedding occasionally has been detected upon experimental BRSV re-infection, clinical disease is seldom observed (Kimman et al., 1987; Tjornehoj, 2000; Taylor et al.,

In this work, we consider a scenario of a humanoid robot learning to perform a visuo-motor task, such as grasping a table at a specific point, by observing motion of the human hand